Following pathological diagnosis of clinical cases, we randomly collected 10 individual samples of cancer and adjacent tissues from OSCC patients in early stage and middle & advanced stage, respectively, for H&E and IHC staining, and then analyzed the relationship between HER2 expression and tumor progression. This evidence concerns the gene ERBB2 and cancer.